Sudo Biosciences

0 followers


Sudo Biosciences is a biopharmaceutical company committed to designing and developing novel, best-in-class medicines to transform patients’ lives. Their lead programs target the tyrosine kinase 2 (TYK2) pseudokinase domain. TYK2 is a key mediator in cytokine signaling pathways that have been linked... Read more

Org chart

Scott Byrd
Chief Executive Officer

Scott Byrd

Collapse
Gordon McMurray
Chief Development Officer
Ian W. Mills
Chief Medical Officer
Anjali Pandey
Svp, Medicinal Chemistry
Imran B.
Chief Business And Financial Officer